These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 36367834

  • 1. IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients.
    Esmaeilian Y, Hela F, Bildik G, Akin N, İltumur E, Yusufoglu S, Yildiz CS, Keles İ, Vatansever D, Taskiran C, Yakin K, Oktem O.
    Hum Reprod; 2023 Jan 05; 38(1):113-124. PubMed ID: 36367834
    [Abstract] [Full Text] [Related]

  • 2. Exposure of antral follicles to medroxyprogesterone acetate during stimulation does not cause molecular perturbations in gonadotropin-responsiveness and steroidogenic function of granulosa cells in progestin-primed cycles.
    Oktem O, Esmaeilian Y, İltumur E, Yusufoglu S, Çimen DU, Incir S, Yakin K, Ata B, Urman B.
    Hum Reprod; 2024 Oct 01; 39(10):2331-2340. PubMed ID: 39180767
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS, Warzecha AK, Nielsen MV, Andersen CY, Holt MD, Petersen MR, Sopa N, Zedeler A, Englund AL, Pinborg A, Grøndahl ML, Skouby SO, Macklon NS.
    Hum Reprod; 2023 Nov 02; 38(11):2154-2165. PubMed ID: 37699851
    [Abstract] [Full Text] [Related]

  • 6. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N, Abdennebi I, Porcu-Buisson G, Chevalier N, Descat E, Piétin-Vialle C, Goro S, Brussieux M, Pinto M, Pasquier M, Bry-Gauillard H.
    Hum Reprod; 2023 May 02; 38(5):927-937. PubMed ID: 36864699
    [Abstract] [Full Text] [Related]

  • 7. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
    Goldrat O, Gervy C, Englert Y, Delbaere A, Demeestere I.
    Hum Reprod; 2015 Sep 02; 30(9):2184-9. PubMed ID: 26109617
    [Abstract] [Full Text] [Related]

  • 8. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME, Dahhan T, Beerendonk CCM, Fleischer K, Stoop D, Bos AME, Lambalk CB, Schats R, Smeenk JMJ, Louwé LA, Cantineau AEP, de Bruin JP, Linn SC, van der Veen F, van Wely M, Goddijn M.
    Hum Reprod; 2022 Jul 30; 37(8):1786-1794. PubMed ID: 35776109
    [Abstract] [Full Text] [Related]

  • 9. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY, Elbaek HO, Alsbjerg B, Laursen RJ, Povlsen BB, Thomsen L, Humaidan P.
    Hum Reprod; 2015 Oct 30; 30(10):2387-95. PubMed ID: 26209535
    [Abstract] [Full Text] [Related]

  • 10. Impact of letrozole co-treatment during ovarian stimulation with gonadotrophins for IVF: a multicentre, randomized, double-blinded placebo-controlled trial.
    Bülow NS, Skouby SO, Warzecha AK, Udengaard H, Andersen CY, Holt MD, Grøndahl ML, Nyboe Andersen A, Sopa N, Mikkelsen ALE, Pinborg A, Macklon NS.
    Hum Reprod; 2022 Jan 28; 37(2):309-321. PubMed ID: 34792133
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol.
    Poulsen LC, Warzecha AK, Bülow NS, Bungum L, Macklon NS, Yding Andersen C, Skouby SO.
    Hum Reprod; 2022 Jun 30; 37(7):1557-1571. PubMed ID: 35652260
    [Abstract] [Full Text] [Related]

  • 13. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
    Friis Wang N, Skouby SO, Humaidan P, Andersen CY.
    Hum Reprod; 2019 May 01; 34(5):942-948. PubMed ID: 30927415
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, Alhalabi M, Akhondi M, Ansaripour S, Tokhmechy R, Zarandi L, Rizk A, El-Mohamedy M, Shaeer E, Khattab M, Mochtar MH, van der Veen F.
    Hum Reprod; 2017 Jan 01; 32(1):112-118. PubMed ID: 27836979
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
    Buendgen NK, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G.
    Arch Gynecol Obstet; 2013 Oct 01; 288(4):901-4. PubMed ID: 23545834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.